Uncovering Potential: Seres Therapeutics's Earnings Preview

Seres Therapeutics (NASDAQ:MCRB) is set to give its latest quarterly earnings report on Wednesday, 2025-08-06. Here's what investors need to know before the announcement.

Analysts estimate that Seres Therapeutics will report an earnings per share (EPS) of $-2.45.

The market awaits Seres Therapeutics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for ...